Cancer

Carrum Health Selected as Part of Quantum Health’s Preferred Partner™ Program as Centers of Excellence Partner for More Accessible Surgery Care

Expanded partnership gives Quantum Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of…

2 years ago

Aflac named a 2024 CIO 100 award honoree

Foundry's CIO 100 Award recognizes enterprise excellence and innovation in IT COLUMBUS, Ga., Aug. 7, 2024 /PRNewswire/ -- Aflac has…

2 years ago

Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

BOSTON and ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical…

2 years ago

PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024

PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage…

2 years ago

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be…

2 years ago

Immutep to Participate in Upcoming Investor Conferences

SYDNEY, AUSTRALIA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology…

2 years ago

Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer

Company’s academic co-founder from the Wellcome Sanger Institute will lead Quotient’s Somatic Genomics researchCAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE)…

2 years ago

Y-mAbs to Participate in Upcoming Investor Conferences in August

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…

2 years ago

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

2 years ago